Resultados de la búsqueda
Ver todos los resultados
Boycat Boycat Boycat
Home
Grupos
Páginas
Marketplace
Más
Grupos Páginas Marketplace Eventos Blogs Financiamiento Ofertas Courses
Participar
Iniciar sesión Registrarse
Night Mode
Buscar
Entradas
Blogs
Usuarios
Páginas
Grupos
Eventos
  • Ates Karahan @ateskarhan agregó una foto in Health
    2026-05-27 06:24:47 · Translate ·
    Oncology Biosimilar Monoclonal Antibodies market Research Report by End User & Industry Vertical
    "Oncology Biosimilar Monoclonal Antibodies Market Summary: According to the latest report published by Data Bridge Market Research, the Oncology Biosimilar Monoclonal Antibodies Market The global oncology biosimilar monoclonal antibodies market size was valued at USD 1.38 billion in 2025 and is expected to reach USD 2.79 billion by 2033, at a CAGR of 9.10% during the forecast period A...
    0 Commentarios ·0 Acciones ·210 Views ·0 Vista previa
    Please log in to like, share and comment!
  • Kajal Khomane @Kajal agregó una foto in Other
    2026-05-27 11:41:03 · Translate ·
    Biosimilar market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis
    " According to the latest report published by Data Bridge Market Research, the Biosimilar Market The global biosimilar market size was valued at USD 64.93 billion in 2024 and is expected to reach USD 598.55 billion by 2032, at a CAGR of 32.00% during the forecast periodThe market expansion is primarily driven by the growing number of patent expiries of blockbuster biologics and the...
    0 Commentarios ·0 Acciones ·255 Views ·0 Vista previa
    Please log in to like, share and comment!
  • Prasad Shinde @prasadshinde agregó una foto in Health
    2026-03-02 17:28:47 · Translate ·
    Bone Health Innovation: Competitive Landscape and Biosimilar Entry in the Denosumab Market
    "Detailed Analysis of Executive Summary Denosumab Market Size and Share Data Bridge Market Research analyses that the global denosumab market which was USD 2,892.17 million in 2022, would rocket up to USD 7,109.92 million by 2030, and is expected to undergo a CAGR of 11.9% during the forecast period.  With this Denosumab Market report, businesses can get details about market...
    0 Commentarios ·0 Acciones ·1K Views ·0 Vista previa
    Please log in to like, share and comment!
  • James Beck @James agregó una foto in Networking
    2026-02-16 12:40:07 · Translate ·
    Oncology Biosimilar Monoclonal Antibodies Market Trends: Growth, Share, Value, Size, and Analysis By 2033
    "Executive Summary Oncology Biosimilar Monoclonal Antibodies Market Research: Share and Size Intelligence The global oncology biosimilar monoclonal antibodies market size was valued at USD 1.38 billion in 2025 and is expected to reach USD 2.79 billion by 2033, at a CAGR of 9.10% during the forecast period. The credible Oncology Biosimilar Monoclonal...
    0 Commentarios ·0 Acciones ·2K Views ·0 Vista previa
    Please log in to like, share and comment!
  • Vanshika Swami @Vanshika04 agregó una foto in Health
    2026-03-13 05:47:49 · Translate ·
    Biologics and Biosimilars Market by 2031 – Trends, Market News, and Recent Developments
    The biologics and biosimilars market is witnessing remarkable growth globally, driven by increasing prevalence of chronic and life-threatening diseases, rapid technological advancements, and growing adoption of cost-effective therapies. Biologics, derived from living organisms, have transformed the treatment landscape for conditions like cancer, autoimmune disorders, and infectious diseases....
    0 Commentarios ·0 Acciones ·2K Views ·0 Vista previa
    Please log in to like, share and comment!
  • Vanshika Swami @Vanshika04 agregó una foto in Health
    2026-04-23 10:41:21 · Translate ·
    Global Oncology Biosimilars Market Forecast to 2031: Growth Trends and Regional Share Analysis
    The global oncology biosimilars market is witnessing rapid expansion, driven by the increasing prevalence of cancer and the rising demand for cost-effective biologic therapies. Biosimilars, which are highly similar to reference biologic drugs, offer significant cost advantages while maintaining comparable safety and efficacy profiles. As healthcare systems worldwide face growing financial...
    0 Commentarios ·0 Acciones ·1K Views ·0 Vista previa
    Please log in to like, share and comment!
  • Prasad Shinde @prasadshinde agregó una foto in Dance
    2026-03-19 09:44:43 · Translate ·
    The Biologic Pivot: How Adalimumab Biosimilars are Redefining 2026 Market Access and Patient Affordability
    "Latest Insights on Executive Summary Adalimumab Biosimilar Market Market Share and Size Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30 million in 2022, is expected to reach USD 3431.48 million by 2030, at a CAGR of 24.4% during the forecast period 2023 to 2030. The market insights gained through this keyword market research analysis...
    0 Commentarios ·0 Acciones ·1K Views ·0 Vista previa
    Please log in to like, share and comment!
© 2026 Boycat
Spanish
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Términos Privacidad Boycat Community Contact Us Directorio Desarrolladores